Nanogels in The Race for Drug Delivery
2010; Future Medicine; Volume: 5; Issue: 2 Linguagem: Inglês
10.2217/nnm.09.103
ISSN1748-6963
Autores Tópico(s)Hydrogels: synthesis, properties, applications
ResumoNanomedicineVol. 5, No. 2 EditorialFree AccessNanogels in the race for drug deliverySerguei V VinogradovSerguei V VinogradovDepartment of Pharmaceutical Sciencess, College of Pharmacy and Center for Drug Delivery and Nanomedicine, University of Nebraska Medical Center, Omaha, NE, USA. Published Online:11 Feb 2010https://doi.org/10.2217/nnm.09.103AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail Figure 1. Nanogel concept.Figure created as a result of an idea from Alexander Kabanov, University of Nebraska Medical Center, USA. Parts adapted from [9].We are currently witnessing a rapid growth of interest in nanotech applications for medicine, most of them focused on radical improvements of current therapies and diagnostic modalities. After a real boom in the development of novel micro- and nano-sized particulate drug delivery systems (DDS) in academic laboratories and pharmaceutical companies all over the world; however, we have now reached the point when the first 'reality check' can be made and the many limits and shortcomings of existing DDS can be evaluated. The major effect of drug administration in loaded DDS can be determined as a principal change in drug pharmacokinetics and bioavailability. Many current DDS have been developed with the aim of reducing biodegradation or in vivo toxicity of drugs. Others have focused on increasing bioavailability, cell-selective accumulation, or activity of encapsulated drugs after administration. Initial generations of DDS were optimized in cell cultures by modifications of the chemical structure or physicochemical properties in order to effectively modulate cellular drug accumulation, release kinetics and overall therapeutic effect.The most promising DDS have been selected for in vivo evaluation. Here, the principal difficulties started to appear. Despite some success stories, a huge gap between the in vitro properties of DDS and the behavior of nanocarriers following injections into a living body was observed in practically every laboratory. The major cause of these differences was the interaction of the surface of DDS with serum components and fast clearance of 'covered' nanocarriers from blood circulation. Special conditions added to the effect, from kidney 'drainage' or retention of DDS in bypassing organs to accumulation of nanocarriers in fatty and muscular tissues. An extremely effective 'deactivation' factor for administered nanoformulations was the capture of nanocarriers by macrophages of the endothelial reticulum, by alveolar macrophages in lungs, and by macrophage populations in the liver and spleen. An important role in recognition by macrophages was attributed to serum proteins (opsonins) that had adsorbed on the surface of nanocarriers and made them 'visible' to macrophages. Particle size, shape, surface charge and polymer brush density of nanocarriers have been determined to be among the main characteristics responsible for premature clearance. All in all, the doses of administered nanocarrier-loaded drugs that reached tumors or targeted organs (except liver, kidney and spleen) rarely exceeded 5–10% of the injected dose. This means an extremely low observed efficacy of nanodelivery. Even a moderate increase in the efficacy of present DDS has proven to be a real challenge.Per aspera ad astra: fighting deficiencies & limitations of DDSOur initial optimism about rational nanoengineering of DDS and 'smart' design is fading fast after multiple failures of drug nanoformulations in clinical trials. The recent history of nonviral gene delivery gives us stunning examples of the slow shift from the initial simplistic designs of nanocarriers to the 'real-life' complex structures with virus-like properties that would be able to cross multiple biological barriers on their way to efficient nuclear expression in target cells. It is now evident that the size or shape of virus particles, surface properties, pattern of cell-binding proteins and the ability to hide from the immune system determine the invasive power of infection and virus persistence in the organism. Therefore, a promising approach to improve the properties of human constructs may include applying real viral properties or bionics, mimicking nature. In that regard, studies of bloodborne pathogens and infections may shed some light upon the requirements for long-term circulation of nanoparticles in the 10–200 nm range in the blood.Surface decoration of nanosized DDS with targeting ligands recognizing specific cellular receptors in the attempt to mimic endogenous immunoglobulins then became a major approach to systemic delivery of encapsulated drugs. However, in DDS design, factors such as the hydrodynamic shape of nanocarriers were seldom taken in account. The critical cell-binding efficacy of many circulating nanocarriers and their retention in tumors, the blood–brain barrier, and so on, will inversely relate to their size or, more precisely, to the cross-sectional area facing the shearing forces of blood flow. The importance of attaching multiple ligands to the surface of DDS for binding cellular receptors in concert was only recently recognized as an important requirement for efficient systemic targeting; no such restriction was identified for antibody–drug conjugates with a hydrodynamic radius (rh) not exceeding 2 nm. However, the shearing forces of blood flow could 'tear off' already-bound larger nanoparticles with an efficacy in direct proportion to their rh2. Evidently, soft nanocarriers, which are capable of flattening themselves on the vascular surface and simultaneously anchoring in multiple points, have a better chance of specific retention in the targeted site of disease.Ex pluribus unum: nanogels & other nanocarriersNanogels have been included only recently in the long list of known physical nanocarriers, which have found applications as DDS, from supramolecular dendrimers with a rh of less than 10 nm to biodegradable nanoparticles with a rh of up to 1 µm. The term 'nanogels' defines small hydrogel particles formed by physically or chemically crosslinked polymer networks. Dispersed in aqueous media, swollen nanogel networks are soft and can encapsulate a considerable volume of water. Biological agents and drugs can be loaded into nanogels via a spontaneous process including interactions between the agent and the polymer matrix, forming hydrophilic particles with high dispersion stability. Nanogels were able to physically protect biological molecules from degradation in vivo and have been preclinically investigated for many types of active molecules, ranging from small drugs to biomacromolecules. Following the first decade of their development, nanogels demonstrated excellent potential for systemic drug delivery, design of multifunctional nanocarriers (e.g., theranostics) and triggered drug-release applications [1–5]. Key features of nanogels will be discussed below in comparison with the currently most advanced DDS.Solid nanoparticles (SNPs) composed from biodegradable polymers have found applications in various fields of nanomedicine, including drug delivery. Biodegradable solid polymer nanoparticles demonstrated great promise as drug delivery carriers and have high biocompatibility. The drug is usually released from a SNP because of matrix erosion that can be controlled by the polymer content of the nanocarrier. The storage ability of nanoparticles in lyophilized form has generally been good. In theory, biodegradable SNPs can sustainably release the drug, optimizing its pharmaceutical profile over time and, thus, increasing drug efficacy. Alas, currently, predictions of drug pharmacokinetics are difficult because of the poor understanding of in vivo biodistribution and behavior of nanocarriers. Moreover, some properties of SNPs are not easily compatible with design of next-generation smart nanocarriers. Introduction of outlying stabilizing polymer molecules, targeted moieties and imaging capabilities were found to be notoriously difficult for biodegradable SNPs. By contrast, nanogels sharing many useful properties of SNPs, such as lyophilizing ability and biocompatibility, are devoid of these problems and can be easily modified with various ligands on their surface and in the internal volume of their network.Liposomes have been around for 30 years and extensively studied, so that many liposomal drugs have already been moved into the clinic. Despite the evident advantages of liposomes, these pharmaceutical formulations are far from ideal, with a short shelf-life, significant drug leakage, high accumulation in the liver and so on. Since the introduction of polyethylene glycol (PEG)ylated 'stealth' liposomes, these carriers have advanced immeasurably. However, as was observed repeatedly in clinical trials, intravenously injected PEGylated stealth liposomes may induce acute pseudoallergic reactions associated with complement activation. PEG chains associated with an anionic phosphate moiety of phospholipids were found to trigger several pathways of the human complement system. Similar effects were also observed with the injection of other PEGylated DDS, such as carbon nanotubes. The major advantage of liposomes is their homology with cellular membranes and the ability to fuse with them, releasing the cargo inside the cells. Some cationic and amphiphilic nanogels have also demonstrated prominent membranotropic properties and were able to fuse with cellular membranes, coming very close to liposomes in this capability [6].Polymeric micelles represent the third major class of DDS, although, in a general sense, they may be considered as excipients, surfactant-stabilizers of poorly soluble drugs. When the size of nanocarriers is concerned, micelles will probably lead the group, because they usually have the smallest diameter and are produced from one amphiphilic polymer component. Major minuses of micelles are low storage stability and problems with lyophilization; a relatively low drug encapsulation is another drawback. Recently, a novel advanced approach, so-called 'wet milling' of solid low-soluble drugs, was developed for preparing heavily drug-loaded micelles stabilized by an amphiphilic polymer. Sometimes, the boundary between micelles and nanogels is vague; crosslinked micelles are frequently called nanogels. They have all of the attributes of nanogels, including pore size and environmentally dependent volume change (collapse). The principal advantage of both types of nanocarriers is a high water content, assuring their excellent dispersion stability. Low soluble drugs can be efficiently encapsulated in micelles, while hydrophilic compounds and bioactive macromolecules are the most frequent drug candidates for encapsulation in nanogels.Nanogel-specific properties can be utilized for the design of smart nanocarriers for various types of delivered molecules. The following examples will help to illustrate the extensive potential of nanogel networks for drug delivery. In application to hybrid nanocarriers, formation of hydrogel nanolayers is now considered as one of the best methods for the preparation of stabilized nanocarriers with functionally active metal or mineral cores for imaging or phototherapeutic purposes. Hybrid nanogels containing smaller gold, ferromagnetic, or fluorescent (quantum dot) SNPs can be a useful platform for the development of smart DDS, but the indestructibility of these components gives rise to some potential issues associated with chronic toxicity. Tissue staining is one of the known visible results of metal SNP accumulation. A hydrogel outlayer makes the solid core biocompatible; in view of future 'nano(ro)bot' development this type of supramolecular architecture seems most versatile. Nanogels encapsulating gold SNPs or quantum dots may serve as recent examples of multifunctional theranostics in the initial stage of preclinical development [6].In the second example, an easy and efficient encapsulation of therapeutic proteins into a cholesteryl–pullulan nanogel network was achieved by Akiyoshi et al. in Japan [7]. A protein of interest mixed with a cholesteryl–pullulan molecule formed small nanogel particles with the protein in the core protected by hydrophilic polymer chains. Various proteins were shown to become more stable, or active, or be delivered into targeted cells more efficiently.A strong focus of recent research has been the engineering of particles with definite shapes, a pharmaceutical parameter having received little attention in the past. As recently became evident, spherical particles are subjected to stronger phagocytosis than ellipsoid or disc-shaped ones. Therefore, rational shape design may provide an additional advantage in drug delivery, avoiding capture by macrophages. In the third example, uniform nanogels have been fabricated by lithographic PRINT process using master-mold process in various shapes and sizes. This innovative PRINT technology that allowed preparation of drug-loaded, shape- and size-optimized uniform nanocarriers was developed by DeSimone et al. in the USA and recently distinguished by NIH and MIT awards [8].Crosslinked hydrogel networks usually form smooth and elastic outlayers that generate extremely low friction with various surfaces, including the endothelium of blood vessels. This property may be useful for the design of cell-associated DDS, so that the biological function of cells circulating in blood/lymphatics will not be affected. Other specific features of nanogels, including stimuli-induced drug release via temperature or pH-dependent volume collapse, can also be very useful in designing smart, stimuli-responsive DDS.Tempus fugit: time is the best judgeThe successful clinical translation of therapeutic nanoformulations requires the optimization of many distinct parameters of nanocarriers, including variation in carrier composition, drug loading and surface properties (polymer or ligand density, hydrophobicity and charge). While various high-throughput or combinatorial methods have been suggested for optimization of biomaterials and DDS, unfortunately, in real life, sometimes those modifications intended to increase a specific efficacy of nanodelivery can suppress other useful properties of nanocarriers, and vice versa. Current pharmacology mostly deals with single drugs and tries to avoid drug interactions. The goal of creating computerized models of drug action, similar to the existing ones in current 'subnano' pharmacology, is only twinkling as a distant star for drug-encapsulated DDS. It is clearly evident that drug nanoencapsulation will not just simplify drug delivery or enhance drug efficacy, but, in its own way will make drug choices and prediction of drug pharmacokinetics more difficult and prone to errors, and influence of many factors associated with DDS.The hype and hope of nanotechnology challenging many previously unimaginable goals are especially high now and many believe in forthcoming breakthroughs in the areas of diagnostic imaging, complementation of diagnostic tools with therapeutic modalities (theranostics), or nanoencapsulation of biotech proteins and novel genetically active macromolecules for clinical applications. However, we must be patient and clear-headed to evaluate the pros and cons of existing DDS. Evidently, only a small fraction of the invented DDS will be able to get over multiple obstacles on their way to clinical studies and, eventually, to the pharmaceutical market of approved drug formulations. The major part of these inventions will remain buried in the archives of the US Patent Office. Our times may still be compared with the period of the California Gold Rush when new gold prospector sites were claimed and even fought over, sometimes without clear idea about their gold content or real outputs. Nanogel nanocarriers are now reaching the age of adolescence and have already demonstrated the promise of a 'wunderkind' child in comparison with other already advanced DDS. Time will judge whether these promises are going to become a reality.Financial & competing interests disclosureThe author is very grateful for support in the development of nanogels from NIH (R01 CA102791, R01 NS050660, R01 CA136921 and R21 NS063879) and from A Kabanov, the director of Center for Drug Delivery and Nanomedicine, UNMC (Omaha, NE, USA). The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.Bibliography1 Kabanov AV, Vinogradov SV: Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew. Chem. Intern. Ed.48,5418–5429 (2009).Crossref, Medline, CAS, Google Scholar2 Raemdonck K, Demeester J, DeSmedt S: Advanced nanogel engineering for drug delivery. Soft Matter5,707–715 (2009).Crossref, CAS, Google Scholar3 Vinogradov SV: Hydrophilic colloidal networks (micro- and nanogels) in drug delivery and diagnostics. In: Structure and Functional Properties of Colloidal Systems. Hidalgo-Alvarez R (Ed.). CRC Press, Taylor & Francis Group, Boca Raton–London–New York, NY, USA 367–386 (2009).Google Scholar4 Yallapu MM, Ready MK, Labhasetwar V: Nanogels: Chemistry to drug delivery. In: Biomedical Applications of Nanotechnology. Labhasetwar V, Leslie-Pelecky DL (Eds). John Wiley & Sons 131–171 (2007).Google Scholar5 Hamidi M, Azadi A, Rafiei P: Hydrogel nanoparticles in drug delivery. Adv. Drug Deliv. Rev.60,1638–1649 (2008).Crossref, Medline, CAS, Google Scholar6 Vinogradov SV: Colloidal microgels in drug delivery applications. Curr. Pharm. Des.12,4703–4712 (2006).Crossref, Medline, CAS, Google Scholar7 Morimoto N, Hasegawa U, Sugawara A, Yamane S, Akiyoshi K: Polysaccharide nanogel engineering: Design of n nano-structured hydrogel materials and application to biotechnology and medicine. In: Nanotechnology in Carbohydrate Chemistry. Yuassa H (Ed.). Transworld Research Network, Trivandrum, India 67–85 (2006).Google Scholar8 Euliss LE, DuPont JA, Gratton S, DeSimone J: Imparting size, shape, and composition control of materials for nanomedicine. Chem. Soc. Rev.35,1095–1104 (2006).Crossref, Medline, CAS, Google Scholar9 Kabanov AV, Batrakova EV. New technologies for drug delivery across the blood brain barrier. Curr. Pharm. Des.10(12),1355–1363 (2004).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByNanogels as novel drug nanocarriers for CNS drug delivery8 August 2023 | Frontiers in Molecular Biosciences, Vol. 10Biodegradable Nanogels for Dermal Applications: An InsightCurrent Nanoscience, Vol. 19, No. 4Multiple nano-drug delivery systems for intervertebral disc degeneration: Current status and future perspectivesBioactive Materials, Vol. 23A REVIEW OF NANOGELS AS NOVEL DRUG DELIVERY SYSTEMS7 April 2023 | Asian Journal of Pharmaceutical and Clinical ResearchPolymer-based particles against pathogenic fungi: A non-uptake delivery of compoundsBiomaterials Advances, Vol. 146CuAAC ensembled 1,2,3-triazole linked nanogels for targeted drug delivery: a review1 January 2023 | RSC Advances, Vol. 13, No. 5Theoretical and applied concepts of nanocarriers for the treatment of Parkinson's diseasesOpenNano, Vol. 9Nanogel-based Transdermal Drug Delivery System: A Therapeutic Strategy with Under Discussed PotentialCurrent Topics in Medicinal Chemistry, Vol. 23, No. 1Nanogels: Update on the methods of synthesis and applications for cardiovascular and neurological complicationsJournal of Drug Delivery Science and Technology, Vol. 77Recent Developments on Ionic Liquids and Deep Eutectic Solvents for Drug Delivery Applications23 June 2022 | Pharmaceutical Research, Vol. 39, No. 10Recent Applications of Natural Polymers in the Formulation of NanogelCurrent Drug Therapy, Vol. 17, No. 5Beyond particle stabilization of emulsions and foams: Proteins in liquid-liquid and liquid-gas interfacesAdvances in Colloid and Interface Science, Vol. 308Neurospecific fabrication and toxicity assessment of a PNIPAM nanogel encapsulated with trans-tephrostachin for blood-brain-barrier permeability in zebrafish modelHeliyon, Vol. 8, No. 8Nanogels as Novel Nanocarrier Systems for Efficient Delivery of CNS Therapeutics19 July 2022 | Frontiers in Bioengineering and Biotechnology, Vol. 10Recent Advances in Antimicrobial Nano-Drug Delivery Systems29 May 2022 | Nanomaterials, Vol. 12, No. 11Nanoemulgel as an approach to improve the biopharmaceutical performance of lipophilic drugs: Contemporary research and applicationJournal of Drug Delivery Science and Technology, Vol. 72Comparison of carboxybetaine with sulfobetaine polyaspartamides: Nonfouling properties, hydrophilicity, cytotoxicity and model nanogelation in an inverse miniemulsion29 December 2021 | Journal of Applied Polymer Science, Vol. 139, No. 19Current Trends and Applications of Food-derived Antihypertensive Peptides for the Management of Cardiovascular DiseaseProtein & Peptide Letters, Vol. 29, No. 5Carbohydrates Used in Polymeric Systems for Drug Delivery: From Structures to Applications29 March 2022 | Pharmaceutics, Vol. 14, No. 4Glutathione-responsive molecular nanoparticles from a dianionic bolaamphiphile and their use as carriers for targeted deliveryJournal of Colloid and Interface Science, Vol. 608Behaviour of a magnetic nanogel in a shear flowJournal of Molecular Liquids, Vol. 346Strategies to load therapeutics into polysaccharide-based nanogels with a focus on microfluidics: A reviewCarbohydrate Polymers, Vol. 266Protein-Based Nanohydrogels for Bioactive Delivery9 July 2021 | Frontiers in Chemistry, Vol. 9Nano-encapsulation of hydroxytyrosol into formulated nanogels improves therapeutic effects against hepatic steatosis: An in vitro studyMaterials Science and Engineering: C, Vol. 124Non-Polymeric Nanogels as Versatile Nanocarriers: Intracellular Transport of the Photosensitizers Rose Bengal and Hypericin for Photodynamic Therapy1 April 2021 | ACS Applied Bio Materials, Vol. 4, No. 4Dual loading of Nigella sativa oil-atorvastatin in chitosan–carboxymethyl cellulose nanogel as a transdermal delivery system5 April 2021 | Drug Development and Industrial Pharmacy, Vol. 47, No. 4Novel Therapeutic Platform of Micelles and Nanogels from Dopa‐Functionalized Triblock Copolymers16 March 2021 | Small, Vol. 17, No. 17Recent advances in nanocellulose processing, functionalization and applications: a review1 January 2021 | Materials Advances, Vol. 2, No. 6Tailoring size and release kinetics of κ/ι -hybrid carrageenan microgels via a surfactant-assisted technique25 January 2020 | International Journal of Polymeric Materials and Polymeric Biomaterials, Vol. 70, No. 5Nanogels Capable of Triggered Release5 March 2021Magnetic and Fluorescent Nanogels for Nanomedicine18 May 2021Preparation and use of nanogels as carriers of drugs26 July 2021 | Drug Delivery, Vol. 28, No. 1Scaling Laws in the Diffusive Release of Neutral Cargo from Hollow Hydrogel Nanoparticles: Paclitaxel-Loaded Poly(4-vinylpyridine)11 November 2020 | ACS Nano, Vol. 14, No. 11Thermoresponsive Nanogels Based on Different Polymeric Moieties for Biomedical Applications4 July 2020 | Gels, Vol. 6, No. 3The influence of an applied magnetic field on the self-assembly of magnetic nanogelsJournal of Molecular Liquids, Vol. 307Facile preparation of pH/reduction dual-stimuli responsive dextran nanogel as environment-sensitive carrier of doxorubicinPolymer, Vol. 200Polymeric Nanogels for Theranostic Applications: A Mini-ReviewCurrent Nanoscience, Vol. 16, No. 3Suspensions of magnetic nanogels at zero field: Equilibrium structural propertiesJournal of Magnetism and Magnetic Materials, Vol. 498Use of Nanoparticulate Systems for Tackling Neurological Aging20 October 2020Drug delivery nanosystems for musculoskeletal regenerationRecent Advances in Nanocarrier-Based Brain-Targeted Drug Delivery for Effective Treatment of Central Nervous System Disorders31 July 2020Engineered polymeric nanovehicles for drug deliveryEvaluation of cationic core-shell thermoresponsive poly(N-vinylcaprolactam)-based microgels as potential drug delivery nanocarriersMaterials Science and Engineering: C, Vol. 104Crossover of the effective charge in ionic thermoresponsive hydrogel particles6 November 2019 | Physical Review E, Vol. 100, No. 5Poly(ε-caprolactone) (PCL) Hollow Nanoparticles with Surface Sealability and On-Demand Pore Generability for Easy Loading and NIR Light-Triggered Release of Drug13 October 2019 | Pharmaceutics, Vol. 11, No. 10Studying synthesis confinement effects on the internal structure of nanogels in computer simulationsJournal of Molecular Liquids, Vol. 289Crossing biological barriers with nanogels to improve drug delivery performanceJournal of Controlled Release, Vol. 307Formulation and characterization of glibenclamide and quercetin-loaded chitosan nanogels targeting skin permeationTherapeutic Delivery, Vol. 10, No. 5In between molecules and self-assembled fibrillar networks: highly stable nanogel particles from a low molecular weight hydrogelator1 January 2019 | Soft Matter, Vol. 15, No. 17A nanogel based oral gene delivery system targeting SUMOylation machinery to combat gut inflammation1 January 2019 | Nanoscale, Vol. 11, No. 11Application of radiation for the synthesis of poly(n-vinyl pyrrolidone) nanogels with controlled sizes from aqueous solutionsApplied Radiation and Isotopes, Vol. 145Recent progress of polymeric nanogels for gene deliveryCurrent Opinion in Colloid & Interface Science, Vol. 39Nonequilibrium Uptake Kinetics of Molecular Cargo into Hollow Hydrogels Tuned by Electrosteric Interactions24 January 2019 | ACS Nano, Vol. 1Polymeric Nanomedicine8 November 2019Polyethylene Glycol Nanoparticles as Promising Tools for Anticancer TherapeuticspH-triggered poly(ethylene glycol) nanogels prepared through orthoester linkages as potential drug carriers3 January 2018 | International Journal of Polymeric Materials and Polymeric Biomaterials, Vol. 67, No. 18Nanogels as potential drug nanocarriers for CNS drug deliveryDrug Discovery Today, Vol. 23, No. 7NanohydrogelsMaximizing the absorption of small cosolutes inside neutral hydrogels: steric exclusion versus hydrophobic adhesion1 January 2018 | Physical Chemistry Chemical Physics, Vol. 20, No. 4Medical Applications of NanogelsNanogels in the Diagnosis and Treatment of TuberculosisDual Responsive Poly( N -vinylcaprolactam) Based Degradable Microgels for Drug Delivery11 October 2017 | Particle & Particle Systems Characterization, Vol. 34, No. 11Hyaluronic acid nanogels prepared via ortho ester linkages show pH-triggered behavior, enhanced penetration and antitumor efficacy in 3-D tumor spheroidsJournal of Colloid and Interface Science, Vol. 504Biocompatible nanogel derived from functionalized dextrin for targeted delivery of doxorubicin hydrochloride to MG 63 cancer cellsCarbohydrate Polymers, Vol. 171Carbohydrate based Hydrogels for Controlled Release of Cancer Therapeutics31 October 2017The Potential of Stimuli-Responsive Nanogels in Drug and Active Molecule Delivery for Targeted Therapy8 May 2017 | Gels, Vol. 3, No. 2Sorption and Spatial Distribution of Protein Globules in Charged Hydrogel Particles28 April 2017 | Langmuir, Vol. 33, No. 18Hollow polymer particles: a review1 January 2017 | RSC Advances, Vol. 7, No. 83Basic concepts and recent advances in nanogels as carriers for medical applications9 February 2017 | Drug Delivery, Vol. 24, No. 1Nanogels: An overview of properties, biomedical applications and obstacles to clinical translationJournal of Controlled Release, Vol. 240Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery28 June 2016 | Archives of Pharmacal Research, Vol. 39, No. 9Comparison between two different click strategies to synthesize fluorescent nanogels for therapeutic applicationsReactive and Functional Polymers, Vol. 105On the origin of functionalization in one-pot radiation synthesis of nanogels from aqueous polymer solutions1 January 2016 | RSC Advances, Vol. 6, No. 4Water dispersible siloxane nanogels: a novel technique to control surface characteristics and drug release kinetics1 January 2016 | Journal of Materials Chemistry B, Vol. 4, No. 31Influence of droplet size on repulsive and attractive nanoemulsion gelationColloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 484Role of Steric Interactions on the Ionic Permeation Inside Charged Microgels: Theory and Simulations18 June 2015 | Macromolecules, Vol. 48, No. 13Formation of Multiple Structural Formats of DNA in a Bio-Deep Eutectic Solvent16 March 2015 | Macromolecular Chemistry and Physics, Vol. 216, No. 10Developing cutaneous applications of paromomycin entrapped in stimuli-sensitive block copolymer nanogel dispersionsAlba Pujol Brugués, Beatriz Clares Naveros, Ana C Calpena Campmany, Pilar Hernández Pastor, Roser Fisa Saladrigas & Cristina Riera Lizandra20 January 2015 | Nanomedicine, Vol. 10, No. 2Acid degradable poly(vinylcaprolactam)-based nanogels with ketal linkages for drug delivery1 January 2015 | Journal of Materials Chemistry B, Vol. 3, No. 28A Polymerizable Bioionic Liquid Based Nanogel: A New Nanocarrier for an Anticancer Drug7 July 2014 | Macromolecular Chemistry and Physics, Vol. 215, No. 15Macrophages associated with tumors as potential targets and therapeutic intermediatesSerguei Vinogradov, Galya Warren & Xin Wei15 May 2014 | Nanomedicine, Vol. 9, No. 5Nano-NRTIs demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brainNanomedicine: Nanotechnology, Biology and Medicine, Vol. 10, No. 1Ion permeation inside microgel particles induced by specific interactions: from charge inversion to overcharging30 June 2014 | Soft Matter, Vol. 10, No. 31Nanogel carrier design for targeted drug delivery1 January 2014 | J. Mater. Chem. B, Vol. 2, No. 46Interconnected Roles of Scaffold Hydrophobicity, Drug Loading, and Encapsulation Stability in Polymeric Nanocarriers20 November 2012 | Molecular Pharmaceutics, Vol. 9, No. 12Minimalism in Radiation Synthesis of Biomedical Functional Nanogels18 May 2012 | Biomacromolecules, Vol. 13, No. 6Biocompatible and functionalizable polyphosphate nanogel with a branched structureJournal of Materials Chemistry, Vol. 22, No. 18Research HighlightsJason S Kim, Mino Kang, Eva Bagyinszky, Rajangam Thanavel & SeongSoo A An4 May 2011 | Nanomedicine, Vol. 6, No. 3Stimulus responsive nanogels for drug deliverySoft Matter, Vol. 7, No. 13Dual stimuli responsive hollow nanogels with IPN structure for temperature controlling drug loading and pH triggering drug releaseSoft Matter, Vol. 7, No. 18Geographic boundary analysis in spatial and spatio-temporal epidemiology: Perspective and prospectsSpatial and Spatio-temporal Epidemiology, Vol. 1, No. 4Self-Assembled Nanogel Made of Mannan: Synthesis and Characterization2 June 2010 | Langmuir, Vol. 26, No. 13Silver nanoparticles—the real "silver bullet" in clinical medicine?MedChemComm, Vol. 1, No. 2 Vol. 5, No. 2 STAY CONNECTED Metrics History Published online 11 February 2010 Published in print February 2010 Information© Future Medicine LtdFinancial & competing interests disclosureThe author is very grateful for support in the development of nanogels from NIH (R01 CA102791, R01 NS050660, R01 CA136921 and R21 NS063879) and from A Kabanov, the director of Center for Drug Delivery and Nanomedicine, UNMC (Omaha, NE, USA). The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download
Referência(s)